drugset

drugset / Trial / NCT00629590

Safety and Efficacy Pilot Study of AzaSite (Azithromycin) in Subjects With Blepharitis

NCT00629590 ↗

Phase 4 Completed 20 enrolled Merck Sharp & Dohme LLC

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of AzaSite ophthalmic solution, 1% on signs and symptoms of blepharitis.

Timeline

Start: 2008-03
Primary completion: 2008-07
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Azithromycin	Small molecule	—	Other

Indications